Ehninger G - Search Results

1

Combination of mitoxantrone and etoposide in refractory acute myelogenous leukemia--an active and well-tolerated regimen.

Ho AD, Lipp T, Ehninger G, Illiger HJ, Meyer P, Freund M, Hunstein W. Ho AD, et al. Among authors: ehninger g. J Clin Oncol. 1988 Feb;6(2):213-7. doi: 10.1200/JCO.1988.6.2.213. J Clin Oncol. 1988. PMID: 3422260

2

Combination therapy with mitoxantrone and etoposide in refractory acute myelogenous leukemia.

Ho AD, Lipp T, Ehninger G, Meyer P, Freund M, Hunstein W. Ho AD, et al. Among authors: ehninger g. Cancer Treat Rep. 1986 Aug;70(8):1025-7. Cancer Treat Rep. 1986. PMID: 3460698

3

Mitoxantrone and VP-16 in refractory acute myelogenous leukemia.

Ho AD, Lipp T, Ehninger G, Meyer P, Rückle H, Steinke B, Kaboth W, Körbling M. Ho AD, et al. Among authors: ehninger g. Onkologie. 1986 Jun;9(3):148-50. doi: 10.1159/000215990. Onkologie. 1986. PMID: 3528961

4

Mitoxantrone and VP-16 in refractory acute myelogenous leukemia.

Ho AD, Lipp T, Ehninger G, Meyer P, Freund M, Illiger HJ, Körbling M. Ho AD, et al. Among authors: ehninger g. Haematol Blood Transfus. 1987;30:339-42. doi: 10.1007/978-3-642-71213-5_54. Haematol Blood Transfus. 1987. PMID: 3305205 Clinical Trial. No abstract available.

5

Mitoxantrone in the treatment of relapsed and refractory acute leukemia.

Meyer P, Ho AD, Ehninger G, Mjaaland I, Heidemann E, Seither E. Meyer P, et al. Among authors: ehninger g. Invest New Drugs. 1985;3(2):203-6. doi: 10.1007/BF00174171. Invest New Drugs. 1985. PMID: 3860490

6

Mitoxantrone in the treatment of relapsed and refractory acute leukemia.

Ehninger G, Ho AD, Meyer P, Mjaaland I, Ostendorf P, Seither E. Ehninger G, et al. Onkologie. 1985 Jun;8(3):146-8. doi: 10.1159/000215642. Onkologie. 1985. PMID: 3895096

7

Combination of mitoxantrone and etoposide in patients aged over 60 years with untreated acute myelogenous leukemia.

Ehninger G, Fackler-Schwalbe E, Freund M, Heil G, Henke M, Hoelzer D, Hoffmann R, Kurrle E, Link H, Lösch A, et al. Ehninger G, et al. Haematol Blood Transfus. 1990;33:316-7. doi: 10.1007/978-3-642-74643-7_58. Haematol Blood Transfus. 1990. PMID: 2182425 Clinical Trial. No abstract available.

8

High-dose cytosine arabinoside and daunorubicin postremission therapy in adults with de novo acute myeloid leukemia. Long-term follow-up of a prospective multicenter trial.

Heil G, Mitrou PS, Hoelzer D, Freund M, Link H, Ehninger G, Steinke B, Ohl S, Wandt H, Fackler-Schwalbe E, et al. Heil G, et al. Among authors: ehninger g. Ann Hematol. 1995 Nov;71(5):219-25. doi: 10.1007/BF01744371. Ann Hematol. 1995. PMID: 7492624 Clinical Trial.

9

Evidence of a graft-versus-leukemia effect in chronic lymphocytic leukemia after reduced-intensity conditioning and allogeneic stem-cell transplantation: the Cooperative German Transplant Study Group.

Schetelig J, Thiede C, Bornhauser M, Schwerdtfeger R, Kiehl M, Beyer J, Sayer HG, Kroger N, Hensel M, Scheffold C, Held TK, Hoffken K, Ho AD, Kienast J, Neubauer A, Zander AR, Fauser AA, Ehninger G, Siegert W; Cooperative German Transplant Study Group. Schetelig J, et al. Among authors: ehninger g. J Clin Oncol. 2003 Jul 15;21(14):2747-53. doi: 10.1200/JCO.2003.12.011. J Clin Oncol. 2003. PMID: 12860954

10

A multicentre study on intensive induction and consolidation therapy in acute myelogenous leukaemia.

Kurrle E, Ehninger G, Freund M, Heil G, Hoelzer D, Link H, Mitrou PS, Ohl S, Queisser W, Schlimok G, et al. Kurrle E, et al. Among authors: ehninger g. Blut. 1988 May;56(5):233-6. doi: 10.1007/BF00320111. Blut. 1988. PMID: 3285914 Clinical Trial. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

813 results

Search Page